ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,637, issued on Sept. 16.
"Biomarkers for irritable bowel syndrome" was invented by Kevin Whelan (London), Bridgette Wilson (London), Megan Rossi (London), Chris Probert (Liverpool, Great Britain) and Rachael Slater (Liverpool, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of determining the probability that an individual has irritable bowel syndrome and whether the individual will respond to dietary intervention. The present invention also provides a method of determining the probability that an individual with irritable bowel syndrome will respond to dietary intervention. There is also provi...